Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease

For many years, β-blockers have been considered contraindicated in patients with heart failure (HF) and in those with bronchial asthma or even chronic obstructive pulmonary disease (COPD) although without clear evidence of asthma. Today, despite overwhelming evidence of the usefulness of β-blockers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdecchia, Paolo, Cavallini, Claudio, Coiro, Stefano, Riccini, Clara, Angeli, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503302/
https://www.ncbi.nlm.nih.gov/pubmed/34650380
http://dx.doi.org/10.1093/eurheartj/suab116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503302/
https://www.ncbi.nlm.nih.gov/pubmed/34650380
http://dx.doi.org/10.1093/eurheartj/suab116

Ejemplares similares